Analyst Price Targets — NEO
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 29, 2026 12:56 pm | — | Craig-Hallum | $19.00 | $15.79 | TheFly | NeoGenomics price target raised to $19 from $17 at Craig-Hallum |
| April 29, 2026 10:32 am | — | Leerink Partners | $25.00 | $9.02 | TheFly | Leerink upgrades NeoGenomics to Outperform, raises target to $25 |
| February 24, 2026 11:41 am | — | Piper Sandler | $13.00 | $9.97 | TheFly | NeoGenomics price target raised to $13 from $12 at Piper Sandler |
| October 28, 2025 8:10 pm | — | Leerink Partners | $14.00 | $9.92 | TheFly | NeoGenomics price target raised to $14 from $12 at Leerink |
| September 2, 2025 11:10 am | — | Stephens | $11.00 | $8.81 | TheFly | NeoGenomics price target raised to $11 from $6.50 at Stephens |
| August 4, 2025 10:44 am | — | Piper Sandler | $11.00 | $5.67 | TheFly | NeoGenomics price target lowered to $11 from $12 at Piper Sandler |
| July 30, 2025 12:59 pm | — | Morgan Stanley | $8.00 | $5.10 | TheFly | NeoGenomics price target lowered to $8 from $10 at Morgan Stanley |
| July 29, 2025 5:55 pm | — | Needham | $8.00 | $5.25 | StreetInsider | Neogenomics (NEO) PT Lowered to $8 at NeedhamMember Login |
| May 6, 2025 10:42 am | David Westenberg | Piper Sandler | $12.00 | $7.84 | TheFly | NeoGenomics price target lowered to $12 from $18 at Piper Sandler |
| January 11, 2025 7:45 pm | Mark Massaro | BTIG | $18.00 | $14.77 | TheFly | NeoGenomics price target lowered to $18 from $21 at BTIG |
Latest News for NEO
NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that the Company will parti
FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics will participate in the Morgan Stanley 24th Annual Global Healthcare Conference, Sept. 14–16, 2026, in New York.
Shares of NeoGenomics, Inc. (NASDAQ: NEO - Get Free Report) hit a new 52-week high during mid-day trading on Thursday. The company traded as high as $17.46 and last traded at $17.37, with a volume of 1679789 shares. The stock had previously closed at $16.79. Analyst Ratings Changes Several equities analysts have commented on the
Valuation Assessment of NeoGenomics Inc (NEO)On August 26, 2026, NeoGenomics Inc (NEO) shares rose 3.5% today, closing at $17.37. The stock has experienced a no
FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics announced expanded MolDX coverage for its RaDaR® ST MRD assay for immunotherapy monitoring in late-stage solid tumors.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for NEO.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.